Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Prostate |
Black patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Chris Wolski | Sep 4, 2023 | POC Rapid Assays |
Hilab showcased its point-of-care Hemogram device capable of delivering a complete blood count with the assistance of artificial intelligence.
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cancer |
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 17, 2023 | Cancer |
Americans have gotten at least 12 million more years of life to live due to preventive cancer screenings conducted over the past 25 years.
Read More